Category: Cardinal HealthSyndicate content

Cardinal Health struggles but beats The Street in Q4

August 4, 2014 by Arezu Sarvestani

Healthcare giant Cardinal Health posts declines in its major drug business during its 4th quarter, but cost-control measures and gains in its smaller medical supplies division help beat analysts' estimates.

Cardinal Health struggles but beats The Street in Q4

Ohio healthcare giant Cardinal Health (NYSE:CAH) got no Wall Street love after posting estimate-beating earnings today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Sunshine Heart taps Boston Scientific R&D vet for ops role | Personnel Moves

June 23, 2014 by Brad Perriello

Sunshine Heart taps ex-Boston Scientific cardiovascular R&D veteran Brian Brown as its new vice president for operations & technology.

Sunshine Heart taps Boston Scientific R&D vet for ops role | Personnel Moves

Cardinal Health CFO Henderson to step down | Personnel Moves

June 11, 2014 by Brad Perriello

Cardinal Health CFO Jeff Henderson plans to step down next year, as the company looks without and within for his replacement.

Cardinal Health CFO Henderson to step down | Personnel Moves

Cardinal Health (NYSE:CAH) said Jeff Henderson is planning to step down at the end of fiscal 2015 after a decade as its chief financial officer.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014

May 15, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott may look to expand medical device business footprint; Device makers take big writedowns on renal denervation; Cardinal Health closes $320M AccessClosure buy; K2M prices IPO under range at $132M; Allergan board spurns Valeant's $47B offer.

Abbott may look to expand medical device business footprint

May 9, 2014 by Brad Perriello

Abbott may look to expand medical device business footprint

Cardinal Health closes $320M AccessClosure buy

May 12, 2014 by Brad Perriello

Cardinal Health says it closed its $320 million all-cash buyout of AccessClosure and its Mynx extravascular closure technology.

Cardinal Health closes $320M AccessClosure buy

Cardinal Health (NYSE:CAH) said today that it closed its $320 million all-cash acquisition of AccessClosure and its Mynx extravascular closure technology.

The Mynx biodegradable sealant products are designed to close off the femoral artery and then dissolve within 30 days.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cardinal Health nabs AccessClosure for $320M

April 3, 2014 by Arezu Sarvestani

Cardinal Health hopes to give its interventional devices suite a boost with the $320 million acquisition of AccessClosure and its Mynx biodegradable vascular sealants.

Cardinal Health nabs AccessClosure for $320M

Ohio-based Cardinal Health (NYSE:CAH) made a $320 million all-cash bid to acquire AccessClosure and its extravascular closure technology.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Patient Safety Technologies settles shareholder lawsuits over Stryker buyout

March 12, 2014 by Brad Perriello

Patient Safety Technologies agrees to make additional disclosures to settle shareholder lawsuits filed over its impending $120 million buyout by Stryker Corp.

Patient Safety Technologies settles shareholder lawsuits over Stryker buyout

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp